Actrii proteins and use in treating post-capillary pulmonary hypertension

MYPI2026004147A0Undetermined Publication Date: 2021-10-28ACCELERON PHARMA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026004147
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-10
Filing Date
2021-04-27
Publication Date
2021-10-28
Patent Text Reader

Abstract

In some aspects, the disclosure relates to compositions and methods comprising ActRII polypeptides to treat, prevent, or reduce the progression rate and / or severity of post- capillary pulmonary hypertension (PcPH), particularly treating, preventing or reducing the progression rate and / or severity of one or more PcPH-associated complications. No Suitable Fig.
Need to check novelty before this filing date? Find Prior Art